Tag: Prescription Drugs
Trial Begins of Nasal Vaccine for Alzheimer Disease
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
Some Cirrhosis Patients Given Opioid Rx at Outpatient Visits
Authors say primary care providers in particular need more education on the potential harms of opioids in patients with liver disease
ACR: Risk Factors ID’d for Hydroxychloroquine-Related Retinopathy
Independent risk factors for HCQ retinopathy include higher doses, longer duration of use, chronic kidney disease, and Asian race
Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill
Request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness
Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries
Countries included in licensing deal mostly in Africa and Asia and account for more than half of the world's population
AHA: Sacubitril/Valsartan No More Beneficial for Chronic Advanced CHF
No benefit seen versus valsartan for reducing NT-proBNP levels for patients with chronic advanced heart failure and reduced ejection fraction
Pricey Alzheimer Drug Drives Spike in Medicare B Premium: Officials
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
ASN: Daprodustat Noninferior to ESAs for Treating Anemia in CKD
Randomized, open-label, phase 3 trials conducted in patients with chronic kidney disease undergoing, not undergoing dialysis
ASN: Chlorthalidone Aids BP Control in Patients With CKD and HTN
For patients with stage 4 chronic kidney disease and poorly controlled hypertension, addition of low dose of chlorthalidone improves BP control
Oral Nadolol Feasible for the Treatment of Infantile Hemangiomas
Randomized clinical trial shows oral nadolol noninferior to oral propranolol for treatment of infantile hemangiomas